- What we do
With approximately 400 staff and dedicated pharmaceutical production facilities our mission is to protect patients’ health through the quality-assured development and production of biopharmaceuticals.
Developed in-house and with decades of experience, we are the sole manufacturer of Erwinase® (Crisantaspase), an asparaginase enzyme indicated for the treatment of Acute Lymphoblastic Leukaemia (ALL), the most common form of cancer in children.
We are also the sole manufacturer of the UK’s licensed anthrax vaccine, which is produced for and on behalf of the UK government as a strategic biodefence medical countermeasure.
Supported by dedicated staff from across the company and in partnership with our distributer, our strategy is to get our Erwinase product licensed and available to as many children needing treatment around the world as possible.
Mike thrives in an environment of business challenge and ethical transparency, matched with the reward of making a difference in the provision of innovative medicines to patients.Find out more
Director of Production
Shane has a B. Sc. (Hons) degree in Biochemistry and 30 years’ experience in the biopharmaceutical industry.Find out more
Director of Quality
Burleigh has more than 30 years experience across a broad range of senior roles in Quality Assurance, GMP Manufacturing, Operational Excellence, Validation and Process Development/Technology Transfer in the Bio/Pharmaceutical ...Find out more
Director of Regulatory Affairs & Pharmacovigilance
Liz Madichie has extensive operational, strategic and leadership experience in global regulatory, pharmacovigilance and product development strategies, across the bio-pharmaceutical and CRO industry.Find out more
Director of Engineering
Mike has 20 years’ experience in Commissioning and Qualification, technical roles and project management with major Pharmaceutical and Service provider companies, where he has established a track record in the delivery ...Find out more